|
1
|
Cahill TJ, Choudhury RP and Riley PR:
Heart regeneration and repair after myocardial infarction:
Translational opportunities for novel therapeutics. Nat Rev Drug
Discov. 16:699–717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lefer DJ and Marban E: Is cardioprotection
dead? Circulation. 136:98–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malfitano C, Barboza CA, Mostarda C, da
Palma RK, dos Santos CP, Rodrigues B, Freitas SC, Belló-Klein A,
Llesuy S, Irigoyen MC and De Angelis K: Diabetic hyperglycemia
attenuates sympathetic dysfunction and oxidative stress after
myocardial infarction in rats. Cardiovasc Diabetol. 13:1312014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li B, Tian J, Sun Y, Xu TR, Chi RF, Zhang
XL, Hu XL, Zhang YA, Qin FZ and Zhang WF: Activation of NADPH
oxidase mediates increased endoplasmic reticulum stress and left
ventricular remodeling after myocardial infarction in rabbits.
Biochim Biophys Acta. 1852:805–815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu L, Yang G, Zhang X, Wang P, Weng X,
Yang Y, Li Z, Fang M, Xu Y, Sun A and Ge J: Megakaryocytic leukemia
1 (MKL1) bridges epigenetic activation of NADPH oxidase in
macrophages to cardiac ischemia-reperfusion injury. Circulation.
138:2820–2836. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cadenas S: ROS and redox signaling in
myocardial ischemia-reperfusion injury and cardioprotection. Free
Radic Biol Med. 117:76–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asensio-Lopez MDC, Lax A, Fernandez Del
Palacio MJ, Sassi Y, Hajjar RJ and Pascual-Figal DA:
Pharmacological inhibition of the mitochondrial NADPH oxidase
4/PKCalpha/Gal-3 pathway reduces left ventricular fibrosis
following myocardial infarction. Transl Res. 199:4–23. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi S, Liang J, Liu T, Yuan X, Ruan B, Sun
L, Tang Y, Yang B, Hu D and Huang C: Depression increases
sympathetic activity and exacerbates myocardial remodeling after
myocardial infarction: Evidence from an animal experiment. PLoS
One. 9:e1017342014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang BS and Leenen FH: The brain
renin-angiotensin-aldosterone system: A major mechanism for
sympathetic hyperactivity and left ventricular remodeling and
dysfunction after myocardial infarction. Curr Heart Fail Rep.
6:81–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong L, Liu Y, Zhou M, Wang G, Quan D,
Shuai W, Shen C, Kong B, Huang C and Huang H: Targeted ablation of
cardiac sympathetic neurons attenuates adverse post-infarction
remodeling and left ventricle dysfunction. Exp Physiol.
103:1221–1229. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji F, Li Z, Nguyen H, Young N, Shi P,
Fleming N and Liu H: Perioperative dexmedetomidine improves
outcomes of cardiac surgery. Circulation. 127:1576–1584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Menon DV, Wang Z, Fadel PJ, Arbique D,
Leonard D, Li JL, Victor RG and Vongpatanasin W: Central
sympatholysis as a novel countermeasure for cocaine-induced
sympathetic activation and vasoconstriction in humans. J Am Coll
Cardiol. 50:626–633. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parati G and Esler M: The human
sympathetic nervous system: Its relevance in hypertension and heart
failure. Eur Heart J. 33:1058–1066. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Z, Zhao T, Lv S, Gao Y, Masters J and
Weng H: Dexmedetomidine attenuates spinal cord ischemia-reperfusion
injury through both anti-inflammation and anti-apoptosis mechanisms
in rabbits. J Transl Med. 16:2092018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan X, Zhang H, Fan Q, Hu J, Tao R, Chen
Q, Iwakura Y, Shen W, Lu L, Zhang Q and Zhang R: Dectin-2
deficiency modulates Th1 differentiation and improves wound healing
after myocardial infarction. Circ Res. 120:1116–1129. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Jiang C, Jiang J and Qiu L:
Dexmedetomidine protects mice against myocardium
ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS
pathway. Clin Exp Pharmacol Physiol. 44:946–953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han H, Zhu J, Zhu Z, Ni J, Du R, Dai Y,
Chen Y, Wu Z, Lu L and Zhang R: p-Cresyl sulfate aggravates cardiac
dysfunction associated with chronic kidney disease by enhancing
apoptosis of cardiomyocytes. J Am Heart Assoc. 4:e0018522015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu J, Deng G, Tian Y, Pu Y, Cao P and Yuan
W: An in vitro investigation into the role of bone
marrowderived mesenchymal stem cells in the control of disc
degeneration. Mol Med Rep. 12:5701–5708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang B, Ye D and Wang Y: Caspase-3 as a
therapeutic target for heart failure. Expert Opin Ther Targets.
17:255–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Wang H, Hao P, Xue L, Wei S, Zhang
Y and Chen Y: Inhibition of aldehyde dehydrogenase 2 by oxidative
stress is associated with cardiac dysfunction in diabetic rats. Mol
Med. 17:172–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong J, Guo X, Yang S and Li L: The
effects of dexmedetomidine preconditioning on aged rat heart of
ischaemia reperfusion injury. Res Vet Sci. 114:489–492. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nguyen V, Tiemann D, Park E and Salehi A:
Alpha-2 agonists. Anesthesiol Clin. 35:233–245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu W, Yu W, Weng Y, Wang Y and Sheng M:
Dexmedetomidine ameliorates the inflammatory immune response in
rats with acute kidney damage. Exp Ther Med. 14:3602–3608. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Wang J, Qian W, Zhao J, Sun L,
Qian Y and Xiao H: Dexmedetomidine inhibits tumor necrosis
factor-alpha and interleukin 6 in lipopolysaccharide-stimulated
astrocytes by suppression of c-Jun N-terminal kinases.
Inflammation. 37:942–949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hou L, Guo J, Xu F, Weng X, Yue W and Ge
J: Cardiomyocyte dimethylarginine dimethylaminohydrolase1
attenuates left-ventricular remodeling after acute myocardial
infarction: Involvement in oxidative stress and apoptosis. Basic
Res Cardiol. 113:282018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Becher UM, Ghanem A, Tiyerili V, Furst DO,
Nickenig G and Mueller CF: Inhibition of leukotriene C4 action
reduces oxidative stress and apoptosis in cardiomyocytes and
impedes remodeling after myocardial injury. J Mol Cell Cardiol.
50:570–577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jimenez-Fernandez S, Gurpegui M,
Díaz-Atienza F, Perez-Costillas L, Gerstenberg M and Correll CU:
Oxidative stress and antioxidant parameters in patients with major
depressive disorder compared to healthy controls before and after
antidepressant treatment: Results from a meta-analysis. J Clin
Psychiatry. 76:1658–1667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu Q, Lee CF, Wang W, Karamanlidis G,
Kuroda J, Matsushima S, Sadoshima J and Tian R: Elimination of
NADPH oxidase activity promotes reductive stress and sensitizes the
heart to ischemic injury. J Am Heart Assoc. 3:e0005552014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cave AC, Brewer AC, Narayanapanicker A,
Ray R, Grieve DJ, Walker S and Shah AM: NADPH oxidases in
cardiovascular health and disease. Antioxid Redox Signal.
8:691–728. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsushima S, Tsutsui H and Sadoshima J:
Physiological and pathological functions of NADPH oxidases during
myocardial ischemia-reperfusion. Trends Cardiovasc Med. 24:202–205.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Imamura M, Lander HM and Levi R:
Activation of histamine H3-receptors inhibits carrier-mediated
norepinephrine release during protracted myocardial ischemia.
Comparison with adenosine A1-receptors and alpha2-adrenoceptors.
Circ Res. 78:475–481. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zefirov TL, Khisamieva LI, Ziyatdinova NI
and Zefirov AL: Selective blockade of α2-adrenoceptor
subtypes modulates contractility of rat myocardium. Bull Exp Biol
Med. 162:177–179. 2016. View Article : Google Scholar : PubMed/NCBI
|
